A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer (original) (raw)
Baylin, S.B. & Herman, J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet.16, 168–174 (2000). ArticleCASPubMed Google Scholar
Makos-Wales, M. et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med.6, 570–577 (1995). Article Google Scholar
Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res.59, 2307–2312 (1999). CASPubMed Google Scholar
Costello, J.F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet.24, 132–138 (2000). ArticleCASPubMed Google Scholar
Gonzalgo, M.L. et al. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res.57, 594–599 (1997). CASPubMed Google Scholar
Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. & Baylin, S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet.21, 103–107 (1999). ArticleCASPubMed Google Scholar
Toyota, M. et al. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res.60, 4044–4048 (2000). CASPubMed Google Scholar
Gardiner-Garden, M. & Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol.20, 261–282 (1987). Article Google Scholar
Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA93, 9821–9826 (1996). ArticleCASPubMedPubMed Central Google Scholar
Sutcliffe, J.S. et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genet.8, 52–58 (1994). ArticleCASPubMed Google Scholar
Esteller, M., Corn, P.G., Baylin, S.B. & Herman, J.G. A gene hypermethylation profile of human cancer. Cancer Res.61, 3225–3229 (2001). CASPubMed Google Scholar
Soengas, M.S. et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature409, 207–211 (2001). ArticleCASPubMed Google Scholar
Rountree, M.R., Bachman, K.E. & Baylin, S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nature Genet.25, 269–277 (2000). ArticleCASPubMed Google Scholar
Bachman, K.E., Rountree, M.R. & Baylin, S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem.276, 32282–32287 (2001). ArticleCASPubMed Google Scholar
Fuks, F., Burgers, W.A., Brehm, A., Hughes-Davies, L. & Kouzarides, T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nature Genet.24, 88–91 (2000). ArticleCASPubMed Google Scholar
Fuks, F., Burgers, W.A., Godin, N., Kasai, M. & Kouzarides, T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J.20, 2536–2544 (2001). ArticleCASPubMedPubMed Central Google Scholar
Robertson, K.D. et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nature Genet.25, 338–342 (2000). ArticleCASPubMed Google Scholar
Smiraglia, D.J. et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum. Mol. Genet.10, 1413–1419 (2001). ArticleCASPubMed Google Scholar
Chetcuti, A. et al. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res.61, 6331–6334 (2001). CASPubMed Google Scholar
Finch, P.W. et al. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc. Natl Acad. Sci. USA94, 6770–6775 (1997). ArticleCASPubMedPubMed Central Google Scholar
Ugolini, F. et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene18, 1903–1910 (1999). ArticleCASPubMed Google Scholar
Ugolini, F. et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene20, 5810–5817 (2001). ArticleCASPubMed Google Scholar
Nishioka, M. et al. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line. Oncogene19, 6251–6260 (2000). ArticleCASPubMed Google Scholar
White, G.R., Varley, J.M. & Heighway, J. Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31. 1 implicated in breast cancer. Oncogene17, 3513–3519 (1998). ArticleCASPubMed Google Scholar
Bachman, K.E. et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res.59, 798–802 (1999). CASPubMed Google Scholar
Kube, E., Weber, K. & Gerke, V. Primary structure of human, chicken, and Xenopus laevis p11, a cellular ligand of the Src-kinase substrate, annexin II. Gene102, 255–259 (1991). ArticleCASPubMed Google Scholar
Frattini, A., Faranda, S., Zucchi, I. & Vezzoni, P. A low-copy repeat in Xq26 represents a novel putatively prenylated protein gene (CXX1) and its pseudogenes (DXS9914, DXS9915, and DXS9916). Genomics46, 167–169 (1997). ArticleCASPubMed Google Scholar
Nicholls, R.D., Saitoh, S. & Horsthemke, B. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet.14, 194–200 (1998). ArticleCASPubMed Google Scholar
Matsuo, K. et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood97, 3205–3209 (2001). ArticleCASPubMed Google Scholar
Song, C., Xing, D., Tan, W., Wei, Q. & Lin, D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res.61, 3272–3275 (2001). CASPubMed Google Scholar
Heston, W.D. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase. Urology49 (Suppl.), 104–112 (1997). ArticleCASPubMed Google Scholar
Strehl, S., Glatt, K., Liu, Q.M., Glatt, H. & Lalande, M. Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Genomics53, 81–89 (1998). ArticleCASPubMed Google Scholar
Rattner, A. et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl Acad. Sci. USA94, 2859–2863 (1997). ArticleCASPubMedPubMed Central Google Scholar
Chang, J.T. et al. Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium. Hum. Mol. Genet.8, 575–583 (1999). ArticleCASPubMed Google Scholar
Abu-Jawdeh, G. et al. Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy. Lab. Invest.79, 439–447 (1999). CASPubMed Google Scholar
Morin, P.J. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science275, 1787–1790 (1997). ArticleCASPubMed Google Scholar
Behrens, J. et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science280, 596–599 (1998). ArticleCASPubMed Google Scholar